Fluticasone prop HFA 220 MCG 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26FU8TW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,713
Award facts
- Contract value 100% obligated
- $39,712.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,712.97 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 MCG inhalers (12GM) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's federal business demonstrates its capability to fulfill diverse medical supply requirements, from specialty medications and brand-name drugs to vaccines and medical devices across multiple therapeutic domains. This delivery order for respiratory medication supports the military healthcare system's pharmaceutical supply needs and reflects the ongoing reliance on AmerisourceBergen's logistics and distribution infrastructure to deliver essential medications to Defense Health Agency and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FU8TW?
SPE2DR26FU8TW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FU8TW worth?
The government has obligated $39,713 on SPE2DR26FU8TW.
Is contract SPE2DR26FU8TW an order under another contract?
Yes. SPE2DR26FU8TW is a delivery order under SPE2DR25D3112, an indefinite delivery contract.
Was contract SPE2DR26FU8TW competed?
The extent of competition for SPE2DR26FU8TW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award